Analyst Ratings for Mirum Pharmaceuticals (MIRM)
MIRM Rating Summary
MIRM Price Target Summary
- Highest: $132.00 (Citizens)
- Lowest: $95.00 (Baird)
- Average: $118.73
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$118.73 (+37.7%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$118.73 (+37.7%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/17/2026 | RBC Capital » Updated 2/26/2026 |
Joe Kim | New Coverage | Outperform (N/A) |
128.00 (130.00) |
103.10 (86.21) |
-16.38% | Details |
| 9/24/2025 | TD Cowen » Updated 2/26/2026 |
Joseph Thome | New Coverage | Buy (N/A) |
117.00 (115.00) |
73.93 (86.21) |
16.61% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
